FDAnews
www.fdanews.com/articles/179774-anika-therapeutics-scores-ce-mark-for-tendon-injury-treatment

Anika Therapeutics Scores CE Mark for Tendon-Injury Treatment

December 20, 2016

Bedford, Massachusetts-based Anika Therapeutics, Inc. has won CE Mark for its Orthovisc-T, indicated to relieve pain and restore function of tendons damaged by chronic injury and overuse.

Orthovisc-T is designed to provide lubrication and encourage tendon gliding. It is administered via injection into the site of injury.

Orthovisc-T is the latest addition to Anika Therapeutics’ product portfolio. — Cynthia Jessup

View today's stories